You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
新天藥業(002873.SZ):定增後新天生物將持有41.97%股權 董大倫仍為實控人
格隆匯 05-19 20:55

格隆匯5月19日丨新天藥業(002873.SZ)公佈,公司於2020年5月19日召開的第六屆董事會第十三次會議審議通過了《貴陽新天藥業股份有限公司2020年非公開發行A股股票預案》等相關議案,貴陽新天生物技術開發有限公司(以下簡稱“新天生物”)、西安陝核恆華醫藥投資合夥企業(有限合夥)(以下簡稱“陝核恆華”)、上海理成資產管理有限公司(以下簡稱“理成資產”)管理的理成新視野10號私募證券投資基金(以下簡稱“理成10號”)共3名特定投資者為本次非公開發行股票的發行對象。

本次權益變動後,新天生物將持有公司41.97%的股權,仍然為公司的控股股東,董大倫通過持有公司控股股東新天生物80%的股權,為公司的實際控制人。本次權益變動不會導致公司的控股股東、實際控制人發生變化。

本次非公開發行A股股票尚需提交公司股東大會審議通過及取得中國證監會的核準。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account